great milestone and achievement, having mayo clinic on are side. Mayo Clinic will initiate a clinical study to evaluate HMD’s HeraBEAT Plus solution.
This study will recruit low-risk expectant mothers from the Obstetrics and Gynecology Department at Mayo
Clinic in Rochester, Minnesota. The overall study will be guided by an assessment of device functionality
and user acceptability, as well as an evaluation of the impact of the device on expectant mother's
perception of foetal well-being, as measured by standardized surveys.
this will give more confidence for big orders and commercial disturbution deals
great work HMD
- Forums
- ASX - By Stock
- HMD
- Ann: Mayo Clinic clinical study to evaluate HeraBEAT Plus
Ann: Mayo Clinic clinical study to evaluate HeraBEAT Plus, page-2
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HMD (ASX) to my watchlist
|
|||||
Last
1.8¢ |
Change
-0.005(21.7%) |
Mkt cap ! $11.39M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 1.8¢ | $15.18K | 742.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 499999 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 16562 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 499999 | 0.018 |
1 | 18311 | 0.017 |
2 | 2000000 | 0.016 |
2 | 3500000 | 0.015 |
2 | 1500000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 16562 | 2 |
0.024 | 150000 | 1 |
0.025 | 108565 | 2 |
0.030 | 500000 | 1 |
0.031 | 321876 | 2 |
Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
Featured News
HMD (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online